Publicaciones en las que colabora con Manuel de la Mata García (7)

2018

  1. Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study

    American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522

2016

  1. Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma

    Hepatology, Vol. 63, Núm. 2, pp. 488-498

2011

  1. Cyclosporine A-based immunosuppression reduces relapse rate after antiviral therapy in transplanted patients with hepatitis C virus infection: A large multicenter cohort study

    Transplantation, Vol. 92, Núm. 3, pp. 334-340

2009

  1. Pamidronate in the prevention of bone loss after liver transplantation: A randomized controlled trial

    Transplant International, Vol. 22, Núm. 2, pp. 198-206

2006

  1. Daclizumab induction and maintenance steroid-free immunosuppression with mycophenolate mofetil and tacrolimus to prevent acute rejection of hepatic allografts

    Transplant International, Vol. 19, Núm. 8, pp. 641-648

2003

  1. Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation

    Journal of Hepatology, Vol. 39, Núm. 3, pp. 389-396

1999

  1. Late orthotopic liver retransplant: Indications and survival

    Transplantation Proceedings